Lista de obras -

A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation

artículo científico publicado en 2020

A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

scientific article published on 07 April 2020

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

artículo científico publicado en 2009

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

artículo científico publicado en 2017

Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma

scientific article published on 16 March 2006

Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.

artículo científico publicado en 2008

Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients

artículo científico publicado en 2012

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

artículo científico publicado en 2020

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

artículo científico publicado en 2018

C0264 Protein Z mutations in patients with fetal losses: Structural analysis

scholarly article by Giovanni Luca Tiscia et al published October 2012 in Thrombosis Research

Causes of adult splanchnic vein thrombosis in the mediterranean area.

artículo científico publicado en 2011

Cerebral sinus-venous thrombosis

artículo científico

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study

artículo científico publicado en 2014

Cerebral venous thrombosis and the risk of pregnancy-related recurrent venous thromboembolism

artículo científico publicado en 2010

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

artículo científico publicado en 2019

Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene

scientific article published on 01 January 2003

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

artículo científico publicado en 2020

Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome

artículo científico publicado en 2008

Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation

scientific article published on 01 February 2008

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis

scientific article published on 14 June 2019

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

artículo científico publicado en 2020

Full Donor Chimerism After Allogeneic Hematopoietic Stem Cells Transplant For Myelofibrosis: The Role Of The Conditioning Regimen

artículo científico publicado en 2020

G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome

scientific article published on 01 September 2004

Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission

artículo científico publicado en 2015

Haemostatic alterations induced by treatment with asparaginases and clinical consequences

artículo científico publicado en 2014

High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis

artículo científico publicado en 2007

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

artículo científico publicado en 2018

Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.

artículo científico publicado en 2012

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

scientific article published on 07 June 2019

Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.

artículo científico publicado en 2011

In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband

artículo científico publicado en 2011

Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation

artículo científico publicado en 2009

Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?

scientific article published on 05 December 2018

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

artículo científico publicado en 2013

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.

artículo científico publicado en 2009

Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.

artículo científico publicado en 2002

Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications

artículo científico publicado en 2003

Inherited thrombophilia: treatment during pregnancy

scientific article published on 01 January 2006

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach

artículo científico publicado en 2019

JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis

artículo científico publicado en 2011

JAK2-mutated langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib

artículo científico publicado en 2017

Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia

artículo científico publicado en 2010

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

artículo científico publicado en 2019

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

artículo científico publicado en 2018

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study

artículo científico publicado en 2012

Management and outcome of 11 pregnancies in women with polycythemia vera

scientific article published on 08 April 2019

Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years

scientific article published on 21 November 2019

Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies.

artículo científico publicado en 2004

Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation

artículo científico publicado en 2012

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

scientific article published on 24 October 2018

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms.

artículo científico publicado en 2008

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation

scientific article published on 27 July 2018

Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.

artículo científico publicado en 2006

Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients

artículo científico publicado en 2009

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

scientific article published on 11 February 2008

Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk

artículo científico publicado en 2007

Risk factor and etiology analysis of ischemic stroke in young adult patients

artículo científico publicado en 2014

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.

artículo científico publicado en 2018

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

artículo científico publicado en 2013

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

artículo científico publicado en 2015

Screening for inherited thrombophilia: indications and therapeutic implications.

artículo científico publicado en 2002

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

scientific article published on 29 May 2019

Second cancers in MPN: Survival analysis from an international study

artículo científico publicado en 2019

Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura

artículo científico publicado en 2006

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

artículo científico publicado en 2019

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.

artículo científico publicado en 2015

Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications

scientific article published on 30 April 2020

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups

artículo científico publicado en 2013

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

artículo científico publicado en 2018

The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal

artículo científico publicado en 2008

The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia

scientific article published on 01 July 2002

The interaction between small intestinal bacterial overgrowth and warfarin treatment

artículo científico publicado en 2009

The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S

scientific article published on 01 May 2006

The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis

artículo científico publicado en 2006

The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia

artículo científico publicado en 2008

Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

scientific article published on 12 December 2019

Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT

scientific article published on 12 December 2019

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis

scientific article published on 20 May 2020

Venous thromboembolism in multiple myeloma

artículo científico publicado en 2014

Venous thromboembolism in patients with liver diseases

artículo científico publicado en 2015

Lista de obras de

A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation

A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma

Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.

Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

C0264 Protein Z mutations in patients with fetal losses: Structural analysis

Causes of adult splanchnic vein thrombosis in the mediterranean area.

Cerebral sinus-venous thrombosis

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study

Cerebral venous thrombosis and the risk of pregnancy-related recurrent venous thromboembolism

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome

Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Full Donor Chimerism After Allogeneic Hematopoietic Stem Cells Transplant For Myelofibrosis: The Role Of The Conditioning Regimen

G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome

Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission

Haemostatic alterations induced by treatment with asparaginases and clinical consequences

High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.

In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband

Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation

Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.

Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.

Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications

Inherited thrombophilia: treatment during pregnancy

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach

JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis

JAK2-mutated langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib

Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study

Management and outcome of 11 pregnancies in women with polycythemia vera

Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years

Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies.

Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms.

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation

Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.

Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk

Risk factor and etiology analysis of ischemic stroke in young adult patients

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

Screening for inherited thrombophilia: indications and therapeutic implications.

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Second cancers in MPN: Survival analysis from an international study

Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.

Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal

The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia

The interaction between small intestinal bacterial overgrowth and warfarin treatment

The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S

The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis

The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia

Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis

Venous thromboembolism in multiple myeloma